HONG KONG, Feb. 28, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech"or the "Company"), a leading integrated healthcare enterprise in China, announces that Gloden Meditech K.K., an indirect wholly-owned subsidiary of the Company, has completed the acquisition of 50% equity interest in
Details have been published by the Company in accordance with the Rules Governing the Listing of Securities on the Stock Exchange of Hong Kong Limited and posted on the Company's website as follows: http://www.goldenmeditech.com/eng/ir/announcements.php?year=2018
About Golden Meditech Holdings Limited (SEHK stock code: 00801)
Golden Meditech (www.goldenmeditech.com) is a leading integrated-healthcare enterprise in China. It is a first-mover in China, having established its dominant positions in several markets including the medical devices market and the hospital management market in the healthcare industry, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities. Going forward, Golden Meditech will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.
About ASA Asset Management Co., Ltd.
ASA is a company incorporated in Japan. It is principally engaged in the provision of real estate asset management, investment consultancy and property arrangement services (including trust agreement and financial instrument services) with various licences and permits in wealth management. ASA manages offices, residences, commercial facilities, hotels and healthcare houses.
View original content:http://www.prnewswire.com/news-releases/golden-meditechs-subsidiary-completes-acquisition-of-50-equity-interest-in-asa-300605576.html
SOURCE Golden Meditech Holdings Limited
Subscribe to our Free Newsletters!
Take the quiz on Rabies and test your knowledge about this infection that can affect the brain ...
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...View All